Precision genome editing is revolutionizing the treatment of rare genetic disorders, offering hope through customized therapies while raising ethical and medical concerns.

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Researchers at the Texas A&M University Health Science Centre have uncovered a hidden mechanism that drives the growth of one of the most aggressive forms of kidney cancer affecting children and young ...

As the initiative she co-founded celebrates its 10-year anniversary, Chan is pursuing a wildly ambitious goal: unlocking the ...

Breakthroughs in RNA editing and radioligand therapies are poised to take biotech into a new era – driving innovation, growth and new investment opportunities Biotechnology is entering a dynamic new ...

Currently, organoids and spheroids market growth is fueled by regulatory support for non-animal models and heavy investment ...

Dr. Tobias Bexte will share recent advances that overcome key barriers to making NK cell therapies safe, effective and widely ...

Advances in genome editing are transforming the treatment for rare genetic diseases, as seen in the case of seven-month-old ...